
Value of serum-free light chain measurements in response and
Aug 7, 2025 · We retrospectively analyzed the independent value of serial FLC on response and progression assessments in 839 patients with measurable disease by sFLC as well as …
Utility of serum free light chain ratio in response definition in ...
Jan 24, 2020 · Therefore, we performed a study to evaluate the impact of sFLC ratio normalization among patients achieving a CR to treatment, including lack of clonal BMPCs by …
IMWG Guidlines Serum-Free Light Chain | Int Myeloma Fn
The following guidelines from the International Myeloma Working Group describe the potential uses of the serum free light chain (SFLC) assay and distinguish which uses have proved their …
Value of serum-free light chain measurements in response and
Aug 7, 2025 · This study supports the incorporation of serial sFLC measurements for monitoring response and progression in MM, even in patients with electrophoretic measurable disease, …
Impact of sFLC Ratio on Outcome in Patients with MM: Validating the ...
Nov 13, 2019 · The routine use of multiparametric flow cytometry with higher sensitivity to detect residual disease than IHC or the older 4-color flow cytometry, has raised the question as to …
Role of serum-free light chain assay for defining response and ...
The International Myeloma Working Group (IMWG) guidelines recommend using electrophoresis and immunofixation to define response and progressive disease (PD) in immunoglobulin (Ig) …
We retrospectively analyzed the independent value of serial FLC on response and progression assessments in 839 patients with measurable disease by sFLC as well as serum/ urine …
Impact of sFLC Ratio on Outcome in Patients with MM: Validating …
Nov 13, 2019 · The routine use of multiparametric flow cytometry with higher sensitivity to detect residual disease than IHC or the older 4-color flow cytometry, has raised the question as to …
Role of Serum Free Light Chain Assay in Relapsed/Refractory …
Since sFLC have a considerably shorter lifespan than M-protein—with half-lives around 21 days—they can reveal early response to treatment. Thus, sFLCs represent a pivotal tool for …
IMWG & Serum-Free Light Chain Analysis| Int Myeloma Fn
The following guidelines from the International Myeloma Working Group describe the potential uses of the serum free light chain (SFLC) assay and distinguish which uses have proved their …